Results 271 to 280 of about 56,778 (348)

Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.

JAMA Dermatol, 2017
Cho YT, Chen KL, Sheen YS, Yang CW, Liau JY, Cheng YP, Chu CY.   +6 more
europepmc   +1 more source

GPIHBP1 Autoantibody‐Related Hypertriglyceridemia in Children: A Report of Two Cases and a Review of Pediatric Cases From the Literature

Molecular Genetics &Genomic Medicine, Volume 14, Issue 5, May 2026.
We report two young children with severe hypertriglyceridemia lacking monogenic causes. Both were ANA‐positive, with confirmed anti‐GPIHBP1 antibodies. Immunosuppressive therapy (hydroxychloroquine ± prednisolone) effectively reduced triglycerides. GPIHBP1 autoantibody‐related hypertriglyceridemia is an important pediatric cause, requiring accurate ...
Rai‐Hseng Hsu, Wuh‐Liang Hwu, Feng‐Jung Yang, Ni‐Chung Lee, Yin‐Hsiu Chien   +4 more
wiley   +1 more source

Successful Sequential and Additive Drug Challenge With Rapid Oral Desensitization in Rifampicin‐Induced Fever

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We report a 63‐year‐old man with active pulmonary tuberculosis who developed drug‐induced fever after commencing standard anti‐TB therapy. Sequential and additive drug challenge identified rifampicin as the offending agent. The patient subsequently underwent successful rapid oral rifampicin desensitization in an outpatient setting, enabling completion ...
Xin Yue Guo, Constantine Zois
wiley   +1 more source

Mogamulizumab-induced drug eruption during multiagent chemotherapy: A possible CD8⁺ T cell-mediated mechanism. [PDF]

JAAD Case Rep
Inayoshi S, Sugita K.
europepmc   +1 more source

Glanders: Past, Present and Future of a Neglected Zoonosis as a Threat in Veterinary and Human Health

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This review displays a comprehensive overview of glanders, including aetiology, epidemiology, pathogenesis, diagnosis, control strategies and ongoing eradication programs. It has also reviewed differential diagnosis and treatment both in animals and humans as well as organism's antimicrobial properties.
Yahya Kanani, Ahmad Oryan, Abdollah Derakhshandeh   +2 more
wiley   +1 more source

Durvalumab-induced lichenoid eruption: expanding a rarely recognized adverse event and review of the literature. [PDF]

An Bras Dermatol
García-Moronta C, Muñoz-Barba D, León-Pérez FJ, Ramos-Pleguezuelos FM, Sánchez-Díaz M, Arias-Santiago S.   +5 more
europepmc   +1 more source

Ceruminolith removal and otitis externa in a 2‐year‐old male neutered red kangaroo (Osphranter rufus)

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 2‐year‐old, male, neutered red kangaroo (Osphranter rufus) presented for a 9‐month history of right‐sided otic pruritus, ear droop and otitis externa with suspected ceruminolith formation. At initial presentation, computed tomography of the skull was performed, which revealed a non‐contrast‐enhancing mass effect in the ear canal.
Christina Gentry, Alice Blue‐McLendon
wiley   +1 more source

Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report. [PDF]

Cureus
Elliott DC, Veon FL, McBride JD, Levin J.   +3 more
europepmc   +1 more source

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

The Journal of Dermatology, Volume 53, Issue 5, Page 746-757, May 2026.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

Drug Eruptions

Cleveland Clinic Journal of Medicine, 1935
openaire   +1 more source